METABOLIC CARDIOPROTECTOR THERAPY IN PEDIATRIC SPORTS MEDICINE

Our previous studies have demonstrated the importance of early diagnostics and treatment of pathological cardiac transformations in young athletes. The present pilot clinical study is focused on cardioprotective effects of 2-ethyl-6-methyl-3-oxy-pyridine succinate (“Mexicor”, EcoPharmInvest) in youn...

Full description

Saved in:
Bibliographic Details
Published inRossiĭskiĭ kardiologicheskiĭ zhurnal no. 5; pp. 52 - 57
Main Authors L. A. Balykova, S. A. Ivyanskyi, N. I. Urzyaeva, V. P. Balashov, N. V. Ivyanskaya, N. V. Shchekina
Format Journal Article
LanguageEnglish
Russian
Published FIRMA «SILICEA» LLC 01.01.2011
Subjects
cardioprotection
children
effectiveness
mexicor
pilot clinical study
sports medicine
Online AccessGet full text

Cover

More Information
Summary:Our previous studies have demonstrated the importance of early diagnostics and treatment of pathological cardiac transformations in young athletes. The present pilot clinical study is focused on cardioprotective effects of 2-ethyl-6-methyl-3-oxy-pyridine succinate (“Mexicor”, EcoPharmInvest) in young athletes with stress cardiomyopathy. It was demonstrated that Mexicor is at least as effective as creatine phosphate, a “gold standard” medication in sports medicine, for correction of hemodynamic, autonomic, or metabolic disturbances, as well as exercise capacity improvement. The results obtained enable us to increase the range of metabolic medications used in sports cardiology.
ISSN:1560-4071
2618-7620